Inherited Thrombophilia and the Risk of Arterial Ischemic Stroke: A Systematic Review and Meta‐Analysis

Background Inherited thrombophilias are well‐established predisposing factors for venous thromboembolism, but their role in arterial thrombosis, such as arterial ischemic stroke, remains uncertain. We aimed to evaluate the association between inherited thrombophilia (factor V Leiden, prothrombin G20210A mutation, protein C deficiency, protein S deficiency, and antithrombin deficiency) and risk of arterial ischemic stroke in adults. Methods and Results We searched PubMed, EMBASE, and Cochrane Library Databases from inception to December 31, 2018. We included case‐control or cohort studies of adults reporting the prevalence of inherited thrombophilias in those with arterial ischemic stroke and subjects without arterial ischemic stroke. Two reviewers (T.C., E.D.) independently searched the literature and extracted data. Pooled odds ratios (ORs) and 95% CIs were calculated using random‐effects model. We identified 68 eligible studies, which collectively enrolled 11 916 stroke patients and 96 057 controls. The number of studies reporting factor V Leiden, prothrombin G20210A mutation, protein C deficiency, protein S deficiency, and antithrombin deficiency were 56, 45, 15, 17, and 12, respectively. Compared with controls, patients with arterial ischemic stroke were significantly more likely to have the following inherited thrombophilias: factor V Leiden (OR, 1.25; 95% CI, 1.08–1.44; I2=0%), prothrombin G20210A mutation (OR, 1.48; 95% CI, 1.22–1.80; I2=0%), protein C deficiency (OR, 2.13; 95% CI, 1.16–3.90; I2=0%), and protein S deficiency (OR, 2.26; 95% CI, 1.34–3.80; I2=8.8%). Statistical significance was not reached for antithrombin deficiency (OR, 1.25; 95% CI, 0.58–2.67; I2=8.8%). Conclusions Inherited thrombophilias (factor V Leiden, prothrombin G20210A mutation, protein C deficiency, and protein S deficiency) are associated with an increased risk of arterial ischemic stroke in adults. The implications of these findings with respect to clinical management of patients with ischemic stroke require further investigation.

[1]  Natural anticoagulant deficiencies in Thais: A population-based study. , 2019, Thrombosis research.

[2]  H. Kamel,et al.  Clinical Impact of Thrombophilia Screening in Young Adults with Ischemic Stroke. , 2019, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[3]  C. Leissinger,et al.  A cross-sectional analysis of cardiovascular disease in the hemophilia population. , 2018, Blood advances.

[4]  B. Kissela,et al.  Factor VIII, Protein C and Cardiovascular Disease Risk: The REasons for Geographic and Racial Differences in Stroke Study (REGARDS) , 2018, Thrombosis and Haemostasis.

[5]  S. Connolly,et al.  Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source , 2018, The New England journal of medicine.

[6]  Andrew D. Johnson,et al.  Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes , 2018, Nature Genetics.

[7]  D. Nagaraja,et al.  A genetic study of Factor V Leiden (G1691A) mutation in young ischemic strokes with large vessel disease in a South Indian population , 2017, Journal of Clinical Neuroscience.

[8]  Stacy A. Johnson,et al.  Patterns and Appropriateness of Thrombophilia Testing in an Academic Medical Center , 2017, Journal of hospital medicine.

[9]  Deepak L. Bhatt,et al.  Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease , 2017, The New England journal of medicine.

[10]  Kibum Kim,et al.  Stroke diagnosis associated with thrombophilia testing overutilization. , 2017, Thrombosis research.

[11]  S. Misra,et al.  Relationship between Factor V Leiden Gene Variant and Risk of Ischemic Stroke: A Case–Control Study , 2017, Annals of Indian Academy of Neurology.

[12]  M. Atadzhanov,et al.  HIV infection, hypercoagulability and ischaemic stroke in adults at the University Teaching Hospital in Zambia: a case control study , 2017, BMC Infectious Diseases.

[13]  S. Goldhaber,et al.  Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban) , 2017, Circulation.

[14]  C. Schooling,et al.  Plasma levels of the anti-coagulation protein C and the risk of ischaemic heart disease , 2016, Thrombosis and Haemostasis.

[15]  T. Miyata,et al.  Thrombophilia in East Asian countries: are there any genetic differences in these countries? , 2016, Thrombosis Journal.

[16]  M. Spiroski,et al.  Vascular Genetic Variants and Ischemic Stroke Susceptibility in Albanians from the Republic of Macedonia , 2016, Open access Macedonian journal of medical sciences.

[17]  J. Lee,et al.  Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study , 2016, The Lancet Neurology.

[18]  A. Hvas,et al.  Thrombophilia testing in young patients with ischemic stroke. , 2016, Thrombosis research.

[19]  N. Erten,et al.  Prevalence Of Thrombophilic Mutations In Ischemic Stroke Patients In Isparta, Turkey , 2015 .

[20]  J. Filipovský,et al.  Tobacco smoking strongly modifies the association of prothrombin G20210A with undetermined stroke: consecutive survivors and population-based controls. , 2015, Atherosclerosis.

[21]  A. Tavernarakis,et al.  Polymorphisms in prothrombotic genes in young stroke patients in Greece: a case-controlled study , 2015, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[22]  J. O’Connell,et al.  Prothrombin G20210A Mutation Is Associated With Young-Onset Stroke: The Genetics of Early-Onset Stroke Study and Meta-Analysis , 2014, Stroke.

[23]  V. V. Solter,et al.  The role of classic risk factors and prothrombotic factor gene mutations in ischemic stroke risk development in young and middle-aged individuals. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[24]  M. Behari,et al.  Prediction of ischemic stroke in young Indians: is thrombophilia profiling a way out? , 2013, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[25]  J. O’Connell,et al.  Factor V leiden and ischemic stroke risk: the Genetics of Early Onset Stroke (GEOS) study. , 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[26]  Comparative analysis of associations between polymorphic variants of the F2, F5, GP1BA, and ACE genes and the risk of developing stroke in Russian and Ukrainian populations , 2013, Molecular Genetics, Microbiology and Virology.

[27]  M. Wintermark,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.

[28]  M. Sartori,et al.  G1691A factor V and G20210A FII mutations, acute ischemic stroke of unknown cause, and patent foramen ovale. , 2012, Thrombosis research.

[29]  D. Radojkovic,et al.  Prothrombotic Genetic Risk Factors in Stroke , 2012, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[30]  M. Endres,et al.  Thrombophilia screening in young patients with cryptogenic stroke , 2012, Hämostaseologie.

[31]  P. Angchaisuksiri Venous thromboembolism in Asia – an unrecognised and under-treated problem? , 2011, Thrombosis and Haemostasis.

[32]  F. Leebeek,et al.  Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review , 2011, Journal of thrombosis and haemostasis : JTH.

[33]  Prothrombin G20210A and Factor V Leiden Polymorphisms in Stroke , 2011, Journal of Molecular Neuroscience.

[34]  M. Fisher,et al.  Testing for Inherited Thrombophilias in Arterial Stroke: Can It Cause More Harm Than Good? , 2010, Stroke.

[35]  S. Kittner,et al.  Meta-Analysis of Factor V Leiden and Ischemic Stroke in Young Adults: The Importance of Case Ascertainment , 2010, Stroke.

[36]  S. Kravchenko,et al.  Ischemic stroke in Ukrainian population: possible involvement of the F2 G20210A, F5 G1691A and MTHFR C677T gene variants , 2010 .

[37]  T. Klockgether,et al.  Common genetic coagulation variants are not associated with ischemic stroke in a case-control study , 2010, Neurological research.

[38]  F. Kirkham,et al.  Impact of Thrombophilia on Risk of Arterial Ischemic Stroke or Cerebral Sinovenous Thrombosis in Neonates and Children: A Systematic Review and Meta-Analysis of Observational Studies , 2010, Circulation.

[39]  A. Folsom,et al.  Novel Hemostatic Factor Levels and Risk of Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study , 2010, Cerebrovascular Diseases.

[40]  A. Mokdad,et al.  Gene polymorphisms in association with self-reported stroke in US adults , 2010, The application of clinical genetics.

[41]  E. Stępień,et al.  Factor XIII Val34Leu polymorphism and ischaemic stroke in patients with patent foramen ovale , 2009, Thrombosis and Haemostasis.

[42]  M. Behari,et al.  Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians. , 2009, Thrombosis research.

[43]  N. D. de Bosch,et al.  Factor V Leiden and the risk of venous thrombosis, myocardial infarction, and stroke: a case-control study in Venezuela. , 2009, Genetic testing and molecular biomarkers.

[44]  A. C. Yazici,et al.  Prevalence of Thrombophilic Mutations and ACE I/D Polymorphism in Turkish Ischemic Stroke Patients , 2009, Clinical and applied thrombosis/hemostasis.

[45]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[46]  H. ten Cate,et al.  Is thrombin a key player in the 'coagulation-atherogenesis' maze? , 2009, Cardiovascular research.

[47]  A. Grau,et al.  Do common prothrombotic mutations influence the risk of cerebral ischaemia in patients with patent foramen ovale? , 2009, Thrombosis and Haemostasis.

[48]  N. Kıylıoğlu,et al.  Hereditary Thrombophilic Factors in Stroke Due to Cerebral Infarct , 2009, The American journal of the medical sciences.

[49]  Yajie Wang,et al.  The coagulation factor V Leiden, MTHFRC677T variant and eNOS 4ab polymorphism in young Chinese population with ischemic stroke. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[50]  M. Schindewolf,et al.  Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis? , 2008, Thrombosis research.

[51]  D. Tanné,et al.  Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. , 2008, Blood.

[52]  Lina Badimon,et al.  Thrombin and protease-activated receptors (PARs) in atherothrombosis , 2008, Thrombosis and Haemostasis.

[53]  Lower Contribution of Factor V Leiden or G202104 Mutations to Ischemic Stroke in Patients With Clinical Risk Factors , 2007, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[54]  L. Iacoviello,et al.  Inherited thrombophilia and stratification of ischaemic stroke risk among users of oral contraceptives , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[55]  J. Martí-Fàbregas,et al.  Diagnostic yield of prothrombotic state studies in cryptogenic stroke , 2006, Acta neurologica Scandinavica.

[56]  C. McCollum,et al.  Young Adult Myocardial Infarction and Ischemic Stroke: the role of paradoxical embolism and thrombophilia (The YAMIS Study). , 2006, Journal of the American College of Cardiology.

[57]  M. Prins,et al.  A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation. , 2006, Blood.

[58]  P. Mannucci,et al.  Oral contraceptive use, thrombophilia and their interaction in young women with ischemic stroke. , 2006, Haematologica.

[59]  G. Assenza,et al.  A role of TNF‐α gene variant on juvenile ischemic stroke: a case–control study , 2005 .

[60]  G. Modi,et al.  Protein S deficiency in HIV associated ischaemic stroke: an epiphenomenon of HIV infection , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[61]  T. Ulutin,et al.  Factor V Leiden Mutation in Cerebrovascular Disease , 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[62]  A. Algra,et al.  Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke , 2005, Journal of thrombosis and haemostasis : JTH.

[63]  B. Gigante,et al.  Polymorphisms in prothrombotic genes and their impact on ischemic stroke in a Sardinian population , 2005, Thrombosis and Haemostasis.

[64]  A. Padovani,et al.  Cumulative Effect of Predisposing Genotypes and Their Interaction With Modifiable Factors on the Risk of Ischemic Stroke in Young Adults , 2005, Stroke.

[65]  J. Rovenský,et al.  Factor V Leiden and Prothrombin G20210A Mutations and the Risk of Atherothrombotic Events in Systemic Lupus Erythematosus , 2004, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[66]  D. Corella,et al.  Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke , 2004, Thrombosis and Haemostasis.

[67]  D. Singer,et al.  Factor V Leiden and Risk of Ischemic Stroke in Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study , 2003, Journal of Thrombosis and Thrombolysis.

[68]  R. Becker,et al.  Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. , 2003, American heart journal.

[69]  A. Kondacs,et al.  Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke , 2003, Journal of neurology, neurosurgery, and psychiatry.

[70]  C. Wolfe,et al.  Ethnic Differences in Markers of Thrombophilia: Implications for the Investigation of Ischemic Stroke in Multiethnic Populations: The South London Ethnicity and Stroke Study , 2003, Stroke.

[71]  B. Peterlin,et al.  Prothrombotic gene polymorphisms and atherothrombotic cerebral infarction , 2003, Acta neurologica Scandinavica.

[72]  M. Hillbom,et al.  Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[73]  Yung-Yee Chang,et al.  The Prevalence of Protein C, Protein S, and Antithrombin III Deficiency in non-APS/SLE Chinese Adults with Noncardiac Cerebral Ischemia , 2003, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[74]  B. Nordestgaard,et al.  Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses. , 2002, Blood.

[75]  A. Arnold,et al.  No Association of Plasma Prothrombin Concentration or the G20210A Mutation with Incident Cardiovascular Disease , 2002, Thrombosis and Haemostasis.

[76]  K. Furie,et al.  A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. , 2001, The New England journal of medicine.

[77]  H. Kwiecinski,et al.  Factor V Leiden, Prothrombin Gene G20210A Variant, and Methylenetetrahydrofolate Reductase C677T Genotype in Young Adults With Ischemic Stroke , 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[78]  M. Prins,et al.  A Prospective Study of Asymptomatic Carriers of the Factor V Leiden Mutation To Determine the Incidence of Venous Thromboembolism , 2001, Annals of Internal Medicine.

[79]  G. Hankey,et al.  Inherited Thrombophilia in Ischemic Stroke and Its Pathogenic Subtypes , 2001, Stroke.

[80]  J Q Shi,et al.  A sensitivity analysis for publication bias in systematic reviews , 2001, Statistical methods in medical research.

[81]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[82]  B. Damasceno,et al.  Inherited Thrombophilia as a Risk Factor for the Development of Ischemic Stroke in Young Adults , 2000, Thrombosis and Haemostasis.

[83]  P. Ridker,et al.  G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. , 1999, Circulation.

[84]  D. De Lucia,et al.  Association of elevated levels of prothrombin fragment 1+2 and Arg506 to Gln mutation in patients with a history of ischemic stroke. , 1999, Journal of neurosurgical sciences.

[85]  N. Erba,et al.  Genetic Abnormalities of the Protein C System: Shared Risk Factors in Young Adults with Migraine with Aura and with Ischemic Stroke? , 1998, Cephalalgia : an international journal of headache.

[86]  H. Lutsep,et al.  Lack of prothrombin gene mutation in young stroke patients , 1998 .

[87]  L. Kuller,et al.  Factor V Leiden Is not a Risk Factor for Arterial Vascular Disease in the Elderly: Results from the Cardiovascular Health Study , 1998, Thrombosis and Haemostasis.

[88]  T. Raghunathan,et al.  Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A) , 1998, Stroke.

[89]  L. Iacoviello,et al.  A hypercoagulable state in activated protein C resistant patients with ischemic stroke , 1998, International journal of clinical & laboratory research (Print).

[90]  M. Fischer,et al.  The 20210A allele of the prothrombin gene: a risk factor for juvenile stroke? Result of a pilot study. , 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[91]  F. Woimant,et al.  Thrombophilia due to 20210 G-->A prothrombin polymorphism and cerebral ischemia in the young. , 1997, Stroke.

[92]  F. Woimant,et al.  Different contribution of factor V Leiden-associated hypercoagulability to ischaemic cerebrovascular disease in the elderly. , 1997, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[93]  Y. Shinohara,et al.  Low Prevalence of Activated Protein C Resistance and Factor V Leiden in Ischemic Stroke in Japan , 1996 .

[94]  R. Press,et al.  Ischemic stroke in the elderly. Role of the common factor V mutation causing resistance to activated protein C. , 1996, Stroke.

[95]  J. Barrett,et al.  Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[96]  P. Ridker,et al.  Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. , 1995, The New England journal of medicine.

[97]  W. Halbmayer,et al.  The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[98]  S. Mayer,et al.  Free Protein S Deficiency in Acute Ischemic Stroke: A Case‐Control Study , 1993, Stroke.